U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513480) titled 'Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH' on March 02.
Brief Summary: Women with PCOS with high AMH randomly allocated into group A & B.Cyproterone acetate plus ethinyl estradiol,metformin & myoinositol in group A and Cyproterone acetate plus ethinyl estradiol & metformin are given in group B.Then letrozole 5 mg day 2 to day 6 is given & ovarian response is seen in day 12 for 3 subsequent 3 months .
Study Start Date: Aug. 12, 2024
Study Type: INTERVENTIONAL
Condition:
PCOS
Intervention:
DRUG: Cyproterone Acetate, Ethinyl Estradiol Drug Combination
Once daily Cyclically for 3 months
DRUG: Metf...